Published online Dec 8, 2015. doi: 10.4254/wjh.v7.i28.2781
Peer-review started: May 8, 2015
First decision: September 8, 2015
Revised: November 3, 2015
Accepted: November 24, 2015
Article in press: November 25, 2015
Published online: December 8, 2015
Processing time: 217 Days and 19.8 Hours
Hepatocellular carcinoma (HCC) is the predominant subject of liver malignancies which arouse global concern. Advanced studies have found that long noncoding RNAs (lncRNAs) are differentially expressed in HCC and implicate they may play distinct roles in the pathogenesis and metastasis of HCC. However, the underlying mechanisms remain largely unclear. In this review, we summarized the functions and mechanisms of those known aberrantly expressed lncRNAs identified in human HCC tissues. We hope to enlighten more comprehensive researches on the detailed mechanisms of lncRNAs and their application in clinic, such as being used as diagnostic and prognostic biomarkers and the targets for potential therapy. Although studies on lncRNAs in HCC are still deficient, an improved understanding of the roles played by lncRNAs in HCC will lead to a much more effective utilization of those lncRNAs as novel candidates in early detection, diagnosis, prevention and treatment of HCC.
Core tip: Hepatocellular carcinoma (HCC) is a global concern. Long noncoding RNAs (lncRNAs) are likely to play crucial roles in various pathogenesis of HCC, including tumor growth, proliferation, invasion, metastasis and recurrence. Here, we focus on recent studies of human HCC associated lncRNAs and highlight their functions, mechanisms, as well as their potential to act as novel candidates for early detection, diagnosis, prevention and treatment of HCC.